Quantitative analysis of tumor shrinkage due to chemotherapy and its implication for radiation treatment planning in limited-stage small-cell lung cancer

BACKGROUND: The optimal timing of chemoradiotherapy in limited-stage small-cell lung cancer (LS-SCLC) hasn’t been established, although evidence from studies supported that patients can benefit from early radiation therapy. The purpose of this study was to quantify tumor shrinkage in response to ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Bing, Wang, Jia-Zhou, Liu, Qi, Cheng, Jing-Yi, Zhu, Zheng-Fei, Fu, Xiao-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851276/
https://www.ncbi.nlm.nih.gov/pubmed/24040865
http://dx.doi.org/10.1186/1748-717X-8-216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851276/
https://www.ncbi.nlm.nih.gov/pubmed/24040865
http://dx.doi.org/10.1186/1748-717X-8-216

Ejemplares similares